Congruently, several reports suggest that NF-κB inhibition suppresses cardiac hypertrophy although a direct role of macrophage RelA has yet to be established in vivo (Andersen et al., 2012; Gaspar-Pereira et al., 2012). The gene discussed is NFKB1; the disease is cardiac hypertrophy.